News

September Home Prices Show Slower Growth Amidst High Rates

September Home Prices Show Slower Growth Amidst High Rates

Insights on September Home Price Trends

The S&P Cotality Case-Shiller U.S. National Home Price NSA Index recorded a modest 1.3% annual gain in September. This marks a slight decline from the 1.4% rise noted in the preceding month, reflecting the challenging landscape of the housing market.

Impact of Inflation on Housing

Current inflation levels have surpassed home price increases for four months straight. In September, the Consumer Price Index (CPI) was 1.7 percentage points ahead of housing appreciation, illustrating a trend that has become more pronounced since June.

Widespread Declines Across Markets

All 20 metropolitan areas monitored by the index showed month-over-month declines prior to seasonal adjustments in September. This signifies a widespread weakening within the market as elevated mortgage rates severely impact affordability and demand.

Market Analysis

"The housing market's deceleration accelerated in September, with the National Composite posting just a 1.3% annual gain—the weakest performance since mid-2023," remarked Nicholas Godec, Head of Fixed Income Tradables & Commodities at S&P Dow Jones Indices. "This decline from last August's 1.4% marks a stark contrast compared to the double-digit increases seen during the early post-pandemic recovery period."

Regional Disparities

The analysis further indicates that Chicago leads the way with a 5.5% annual gain, followed closely by New York at 5.2% and Boston at 4.1%. These northeastern and midwestern cities have maintained their upward momentum despite the general market softening. Conversely, Tampa saw a 4.1% annual decline—the sharpest drop among the tracked metros—followed by similar declines in Phoenix (-2.0%), Dallas (-1.3%), and Miami (-1.3%). These figures highlight ongoing weaknesses in Sun Belt markets that experienced dramatic price surges during the pandemic.

Shifting Market Dynamics

The geographic shift in real estate trends is significant; pandemic-favored markets, particularly in states like Florida, Arizona, and Texas, are now facing declines, whereas traditionally stable cities in the Northeast and Midwest continue to report solid gains. This suggests a return to pre-pandemic dynamics where job markets and urban fundamentals drive appreciation more than temporary migration trends.

Mortgage Rates and Market Performance

Looking at September's performance, all tracked metros reported month-over-month declines before seasonal adjustments, with Tampa witnessing a decrease of 1.0%, San Diego at 0.9%, and Seattle at 0.9%. Although the National Index showed a slight 0.2% gain post-seasonal adjustments, the overarching trend indicates that high mortgage rates—hovering around 6.3%—are significantly impacting market supply and stability.

Long-Term Perspectives

Over the past six months, national home prices have only risen by a marginal 0.4%, a figure that is negative when adjusted for inflation. This deceleration in growth is widespread, with only a handful of metros such as Chicago, Cleveland, and Atlanta seeing positive price movements in the same timeframe, while many regions are witnessing outright declines.

Future Outlook

With current conditions revealing persistent headwinds—elevated mortgage rates and decreasing affordability—the market appears to be settling into a phase of minimal price growth or, in certain areas, outright decline. This environment presents challenges for buyers, sellers, and real estate investors alike.

Year-Over-Year Changes

The S&P Cotality Case-Shiller U.S. National Home Price NSA Index, which aggregates data across nine U.S. census divisions, reported a 1.3% annual gain for September, a decline from the previous month’s 1.4% increase. The 10-City Composite Index showed a yearly increase of 2.0%, slightly down from 2.1%, while the 20-City Composite reported a 1.4% rise, down from 1.6% last month.

Monthly Variations

The pre-seasonally adjusted findings reveal that both U.S. National and the 10-City Composites experienced respective monthly declines of -0.3% and -0.5% for the 10-City and 20-City indices in September. When seasonally adjusted, the U.S. National Index showed a slight increase of 0.2%, contrasting inconsistently across different metros.

About S&P Dow Jones Indices

S&P Dow Jones Indices stands as a global leader in essential index-based data and research, home to renowned indicators such as the S&P 500 and the Dow Jones Industrial Average. More assets are managed based on our indices than on any other provider in the world. Operating since the invention of the first index in 1884, we have consistently shaped the methods by which investors understand and interact with market dynamics.

For Additional Information

For more insights into the dynamics of residential home prices, homebuilding, and mortgage financing, the team at S&P Dow Jones Indices encourages readers to connect with us. Our interactive blogging platform, IndexologyBlog.com, offers real-time commentary from industry experts while we continue to innovate in the realm of index reporting.

Frequently Asked Questions

What is the S&P Cotality Case-Shiller Index?

The S&P Cotality Case-Shiller Index measures the changes in the price of residential properties in the U.S., providing a comprehensive view of real estate trends.

How does inflation affect home prices?

Inflation can outpace home price growth, leading to a decline in real estate affordability as prices increase slower than overall living costs.

What regions are experiencing the most growth in home prices?

Currently, regions like Chicago and New York are showcasing substantial growth in their home prices, contrasting with declines in markets such as Tampa and Phoenix.

How frequently is the S&P Case-Shiller Index updated?

The S&P Cotality Case-Shiller Index results are published monthly, providing timely insights into housing market fluctuations.

What is the significance of the year-over-year analysis?

Year-over-year comparisons help identify long-term trends in home price appreciation, enabling better market assessments and investment decisions.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Liberty Hill: 50 Years of Grassroots Revolution

Updated Category News Views 6

Half a Century of Community Empowerment You don't see organizations sticking to their guns for fifty years without having something real to offer. Liberty Hill Foundation is celebrating this colossal milestone in style by throwing their weight behind 17 grassroots groups under the 2026 Fund for Change. They're not just tossing money around but are genuinely becoming the...

Continue Reading
Atli Launches: AI-Powered eSIM Revolutionizes Travel

Updated Category News Views 7

What's New in Travel Tech: Atli's Debut Wandering the globe might sound romantic until you realize your phone's a paperweight without the right data. Enter Atli, a shiny new AI-powered travel eSIM service, snugged right into your WhatsApp. This marvel comes from the folks at XForge Mobile and aims to obliterate the hassle of getting connected abroad. You know those...

Continue Reading
SES Sells to AFC Industries: A Strategic M&A Move

Updated Category News Views 7

Nashville's Notable Deal in Industrial Supply On a muggy September day in Nashville, XLCS Partners announced it was at the helm of a noteworthy transaction—the sale of Signature Engineered Solutions (SES) to AFC Industries. Now, this isn't just another corporate shuffle; it's a calculated move in the gritty world of fastening and engineered solutions. The Nitty-Gritty...

Continue Reading
GBI Bio's New CEO Jesse McCool to Propel Growth

Updated Category News Views 6

Jesse McCool stepping into GBI's CEO shoes is the kind of move that makes you sit up straight and take notice. Let me tell you, the biomanufacturing scene is buzzing with this appointment, and McCool's got his work cut out for him in leading GBI Biomanufacturing's shift towards commercial-scale operations while expanding their early-stage biotech portfolio. A Veteran in...

Continue Reading
RTI's $14M Boost: A Game-Changer for Tech Innovators

Updated Category News Views 10

Breaking Ground in Tech Deployment The march toward commercializing new tech can be a nightmare. Ask any innovator trying to leap from lab genius to market ready, and they'll tell you the pathway is paved with hurdles—especially in the rough-and-tumble world of energy and industrial tech. RTI International's latest $14 million move? That's a massive step in leveling the...

Continue Reading
Veteran Marketer Joins The Wisory's Advisory Board

Updated Category News Views 5

Tyrrell Schmidt Joins The Wisory's Board Out of the blue, The Wisory has snatched Tyrrell Schmidt right off the retirement bench. This doesn't seem like just another board seating; it smells like a calculated power play. Schmidt, fresh from her heavyweight stint as Global CMO at TD Bank, adds a spicy dose of marketing prowess to The Wisory's already loaded Advisory Board....

Continue Reading
Albertsons Welcomes Once Upon a Coconut Nationwide

Updated Category News Views 6

Coconut Water Takes Over Grocery Aisles You know, for all the cautious optimism I wield, this here is a move that shows real muscle in the world of coconut water—I mean, slamming into Albertsons' grocery empire is no small potatoes! Once Upon a Coconut has landed its premium hydration cans across all the banners under this giant retailer. From that good ol' familiar...

Continue Reading
K-9 Hero Act Aims to Ease Costs for Retired Dogs' Care

Updated Category News Views 7

Let's Talk About the Loyalty that Dogs Deserve Who would've thought we'd be chatting about our four-legged heroes in a federal setting? But here we are, giving well-deserved attention to those furry federal agents. They're the ones who sniff out bombs and tackle crooks, and they're not asking for a retirement plan with a yacht – just some vet care! What the K-9 Hero Act...

Continue Reading
Crystal Risotti: Leading IT Compliance in Healthcare

Updated Category News Views 6

A Journey Marked by Dedication and Expertise In the demanding world of healthcare technology, where regulations can make or break a company, Crystal Risotti has carved out a space for herself as a leader. Over the last 30 years, she's developed a reputation for blending regulatory expertise with practical business strategies. Her recognition as a Pinnacle Professional of...

Continue Reading
Moore Law Investigates Aardvark Therapeutics' Risks

Updated Category News Views 2

Moore Law Launches Probe Into Aardvark Therapeutics Nobody likes stumbling across bad news over their morning coffee, but sometimes the market loves to keep you on your toes. Now it's Aardvark Therapeutics (NASDAQ: AARD) in the headlines, and not how they'd like. This time, Moore Law PLLC is rolling up its sleeves to dig into potential misconduct by the company's top...

Continue Reading

Top 5 Most Recently Viewed Articles

Rapid Micro Biosystems Unveils Presentation Plans for 2025 Conference

Updated Category News Views 153

Rapid Micro Biosystems Announces Upcoming Presentation Rapid Micro Biosystems, Inc. (NASDAQ: RPID) is thrilled to share that it will present at the prestigious 43rd Annual J.P. Morgan Healthcare Conference. This event offers a significant platform for the company to showcase its innovative approaches in the life sciences sector, with a focus on automation solutions that...

Continue Reading
Stock Strategies: Insights from Top Traders on CNBC

Updated Category News Views 371

Latest Stock Picks from CNBC’s Final Trades In a recent episode of CNBC’s popular segment, traders shared their choices for stocks that could see significant movement. Among those highlighted was Agnico Eagle Mines Limited (AEM), with Kevin Simpson from Capital Wealth Planning citing expectations for robust quarterly earnings, indicating a fifth consecutive quarter of...

Continue Reading
Investigating Claims for Investors of Constellation Brands

Updated Category News Views 136

Understanding the Investor Landscape Regarding Constellation Brands Faruqi & Faruqi, LLP, a prominent name in national securities litigation, is currently investigating potential claims for investors who have recently experienced significant losses with Constellation Brands, Inc. (NYSE: STZ). Investors who incurred losses exceeding $50,000 during the specified period are...

Continue Reading
Anticipating the Crew-8 Splashdown: What to Expect

Updated Category News Views 261

Anticipating the Crew-8 Splashdown: What to Expect NASA, in collaboration with SpaceX, is gearing up for an exciting moment as they prepare for the return of the Crew-8 mission. This mission, featuring astronauts from NASA and a cosmonaut from Roscosmos, marks a significant milestone as they conclude their seven-month expedition aboard the International Space Station....

Continue Reading
AEON Biopharma Tackles NYSE Compliance Challenge Head On

Updated Category News Views 113

AEON Biopharma Faces NYSE American Compliance Notice AEON Biopharma, Inc. (NYSE: AEON) based in Irvine, California, has recently encountered a situation that affects its compliance with NYSE American’s listing standards. The company, known for its pioneering work in the biopharmaceutical sector, focuses on developing a botulinum toxin complex. This situation is centered...

Continue Reading